Life Sciences Greenhouse Investments Announces Appointment of Dr. Ronald P. Thiboutot to the Board of Directors

May 18, 2023 – Harrisburg, PA.  Life Sciences Greenhouse Investments (www.LSGPA.com) is pleased to announce that Ronald P. Thiboutot, PhD, has joined the Board of Directors. Immediately prior to joining the Board Dr. Thiboutot served in various executive-level capacities at LSGPA. Most recently he held the position of Executive Vice President, during which time his responsibilities included identifying promising new areas of technology, reviewing science and business opportunities, and representing LSG Investments on the boards of numerous companies within the portfolio.

“Dr. Thiboutot has decades of experience in both the biopharmaceutical industry and the venture world,” said Board Chair Tom Penn. “This combination makes him ideally suited to continue helping to advance the mission,” he added, “and we are delighted that he agreed to serve LSG Investments in this new capacity.”

Prior to joining LSG Investments in 2002, Dr. Thiboutot was president of RT Consultants, Inc. which provided technical, equipment procurement, and facility design consulting services to the US and EU pharmaceutical industry. Among his other employers were Wyeth Pharmaceuticals, where he was the plant director of the vaccine manufacturing facility located in Marietta, PA; Bristol-Myers Squibb, where he worked in the international technology transfer division; and Baxter Travenol.

 About Life Sciences Greenhouse Investments

Life Sciences Greenhouse Investments provides funding and targeted business advice to help startup life science companies bring life-changing technologies to market. By providing early-stage capital and operational expertise to innovative technologies, fostering company growth, and creating jobs, LSG Investments is strengthening Pennsylvania’s vibrant life sciences ecosystem and improving healthcare outcomes for patients around the world.               

Since LSG Investments was founded in 2002 as Life Sciences Greenhouse of Central PA, the evergreen venture fund has invested $37 million into 72 companies and projects that collectively have created and retained 8,500 direct and indirect jobs in the Commonwealth. Today, more than 152 products developed by LSG Investment-funded companies are currently marketed or in development.

# # #

CONTACT:           Michele Washko
                              mwashko@LSGPA.com
                              (m) 717-514-0436

 

Previous
Previous

Gregory R. Jackson, Ph.D., Joins Life Sciences Greenhouse Investments

Next
Next

MedTech Outlook Names MicroInterventional Devices among “Top 10 Emerging Cardiovascular Device Companies of 2022."